NCT05038111

Medical Records Investigation of Whether Perioperative Dexmedetomidine Will Reduce the Duration of Mechanical Ventilation or Hospital Length of Stay in Patients Undergoing Minimally Invasive Cardiac Surgery

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 81 (actual)
• Sponsor: Far Eastern Memorial Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

The concept of enhanced recovery after surgery (ERAS) is utilizing in multiple specialties widely. Early tracheal extubation is one of the components of ERAS that enhances postoperative recovery and reduces the length of stay in intensive care unit (ICU).Dexmedetomidine is a highly selective, shorter-acting α2-adrenergic receptor agonist that has both analgesic and sedativeeffects.It was associated with decreased mortality, time to extubation, and hospital length of stay in cardiac surgical patients according to previous studies.The purpose of this study was to investigate the effect of perioperative dexmedetomidine on patients undergoing minimally invasive cardiac surgery(MICS) who were early extubated after surgery.

Conditions

• Mechanical Ventilation
• Hospital Length of Stay
• Minimally Invasive Cardiac Surgery

Interventions

Type	Name	Description
DRUG	Dexmedetomidine	perioperative dexmedetomidine infusion

Timeline

• Start date: 2021-03-11
• Primary completion: 2021-03-22
• Completion: 2021-03-25
• First posted: 2021-09-08
• Last updated: 2021-09-08

Locations

1 site across 1 country: Taiwan

Regulatory

• FDA-regulated drug study